Overview
The Column Group (TCG) is a San Francisco-based venture ecosystem and science-driven venture capital firm dedicated to fueling scientific innovation in the life sciences industry. TCG employs an edge-to-edge investment model, supporting early technology platforms, single assets, and later-stage programs from inception through exit, with a focus on building fundamentally strong drug discovery companies.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.